Latest News & Features
Refine Search
Europe
Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim Powell, Vishnu Shankar and Ben Rowlatt of Morgan Lewis provide a detailed analysis. 22 May 2025
Europe
AstraZeneca subsidiary Alexion suffers setback in bid to stop rivals launching biosimilars of blood disorder drug | Ruling concerns an error in original patent application | Decision follows UPC defeat for Alexion over eculizumab patent. 22 May 2025
Americas
South Korean company eyes new business opportunities following Supreme Court ruling | Pfizer had claimed infringement of patent covering Prevenar 13 shot. 22 May 2025
Europe
Etienne Sanz de Acedo tells Tom Phillips that the association is looking at incentives to keep delegates at the official convention centre, which is not in the city centre. 22 May 2025
Americas
A lively session explored findings from a report co-authored by LSIPR sister title WIPR, urging the IP sector to call time on outdated metrics that delay or derail women’s professional progress. 22 May 2025
Americas
Boards of Appeal revokes Genzyme patent, handing win to Accord Healthcare | Teva and Hetero Labs also previously filed oppositions | Patent refers to Cerdelga, part of Sanofi’s Gaucher disease franchise. 20 May 2025
Americas
Trademark association confirms UK host city at opening ceremony after news accidentally shared on social media the day before | New mission statement and four-year plan embraces diversity and inclusion | ‘We are, as an organisation, a citizen of the world’ says CEO. 20 May 2025
Americas
The International Trademark Association launches a regulatory framework for AI at the Annual Meeting in San Diego | Adopted Resolution highlights importance of human oversight in IP decisions. 20 May 2025
Americas
Illumina claims Element’s AVITI sequencing platforms includes patented tech | Biotech firm alleges it infringes its MiSeq and MiniSeq system | Start-up founded by former Illumina employees. 19 May 2025
Big Pharma
Trademark activity surged across major markets in 2024 | Swiss pharma ranks among top foreign portfolios in US, UK and EU | Mainland China is largest filer worldwide despite dip in applications | Several major life sciences companies held strong US trademark portfolios. 15 May 2025